SCHEMBL22018175

SCHEMBL22018175

O=C(O)c1cnn2cccc2c1-c1ccccccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMKK1 Q8N5S9 2/20 0.46
CAMKK2 Q96RR4 2/20 0.46
EPHB3 P54753 7/20 0.44
RIPK2 O43353 1/20 0.44
LCK P06239 1/20 0.44
DHODH Q02127 1/20 0.43
NPC1 O15118 6/20 0.42
RAB9A P51151 6/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
ALDH1A1 P00352 4/20 0.42
MAPT P10636 2/20 0.42
TP53 P04637 1/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
KDM4E B2RXH2 2/20 0.41
HTT P42858 2/20 0.41
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
TYK2 P29597 1/20 0.41
JAK3 P52333 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL416200 0.82 EPHB3 (0.56) CAMKK1CAMKK2EPHB3RIPK2LCK
SCHEMBL22018174 0.81 ALDH1A1 (0.54) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
Hydrochloric Acid SCHEMBL30152645 0.80 EPHB3 (0.55) CAMKK1CAMKK2EPHB3RIPK2LCK
Hydrochloric Acid SCHEMBL19119427 0.80 EPHB3 (0.55) CAMKK1CAMKK2EPHB3RIPK2LCK
SCHEMBL15883629 0.79 NPC1 (0.50) CAMKK1CAMKK2EPHB3RIPK2LCK
SCHEMBL15399063 0.79 NPC1 (0.45) CAMKK1CAMKK2EPHB3RIPK2LCK
SCHEMBL12493142 0.78 EPHB3 (0.49) CAMKK1CAMKK2EPHB3RIPK2LCK
SCHEMBL22853734 0.77 CAMKK1 (0.39) CAMKK1CAMKK2EPHB3RIPK2LCK
SCHEMBL18399563 0.76 MAP4K4 (0.43) CAMKK1CAMKK2EPHB3NPC1RAB9A
SCHEMBL22018172 0.75 IDO1 (0.52) EPHB3RIPK2LCKNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2020-11-10 US disclosed
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE HOLDINGS CORPORATION 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM2, PIM1, PIM3 CAMKK1 331/4885CAMKK2 330/4885EPHB3 4255/4885
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors PIM2, PIM1, PIM3 CAMKK1 331/4885CAMKK2 330/4885EPHB3 4255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.